GRI BIO, Inc. Quarterly Operating Income (Loss) in USD from Q1 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
GRI BIO, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q3 2024.
- GRI BIO, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.13M, a 12.7% increase year-over-year.
- GRI BIO, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$8.31M, a 3.29% increase year-over-year.
- GRI BIO, Inc. annual Operating Income (Loss) for 2023 was -$11.4M, a 409% decline from 2022.
- GRI BIO, Inc. annual Operating Income (Loss) for 2022 was -$2.24M, a 75.8% increase from 2021.
- GRI BIO, Inc. annual Operating Income (Loss) for 2021 was -$9.26M, a 93.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)